Works matching IS 17470277 AND DT 2018 AND VI 92 AND IP 3
Results: 17
Cover Image.
- Published in:
- 2018
- By:
- Publication type:
- Cover Art
Corrigendum.
- Published in:
- 2018
- Publication type:
- Correction Notice
Corrigendum.
- Published in:
- 2018
- Publication type:
- Correction Notice
Design, synthesis and evaluation of a novel series of inhibitors reversing P‐glycoprotein‐mediated multidrug resistance.
- Published in:
- Chemical Biology & Drug Design, 2018, v. 92, n. 3, p. 1708, doi. 10.1111/cbdd.13338
- By:
- Publication type:
- Article
Computational investigation on the binding modes of Rimonabant analogs with CB1 and CB2.
- Published in:
- Chemical Biology & Drug Design, 2018, v. 92, n. 3, p. 1699, doi. 10.1111/cbdd.13337
- By:
- Publication type:
- Article
Extending the scope of amantadine drug by incorporation of phenolic azo Schiff bases as potent selective inhibitors of carbonic anhydrase II, drug‐likeness and binding analysis.
- Published in:
- Chemical Biology & Drug Design, 2018, v. 92, n. 3, p. 1692, doi. 10.1111/cbdd.13335
- By:
- Publication type:
- Article
Pyrimidine‐based pyrazoles as cyclin‐dependent kinase 2 inhibitors: Design, synthesis, and biological evaluation.
- Published in:
- Chemical Biology & Drug Design, 2018, v. 92, n. 3, p. 1683, doi. 10.1111/cbdd.13334
- By:
- Publication type:
- Article
New 1,2,3‐triazole‐based analogues of benznidazole for use against Trypanosoma cruzi infection: In vitro and in vivo evaluations.
- Published in:
- Chemical Biology & Drug Design, 2018, v. 92, n. 3, p. 1670, doi. 10.1111/cbdd.13333
- By:
- Publication type:
- Article
Trypanosoma cruzi biochemical changes and cell death induced by an organometallic platinum‐based compound.
- Published in:
- Chemical Biology & Drug Design, 2018, v. 92, n. 3, p. 1657, doi. 10.1111/cbdd.13332
- By:
- Publication type:
- Article
Synthesis and biological evaluation of novel N‐aryl‐ω‐(benzoazol‐2‐yl)‐sulfanylalkanamides as dual inhibitors of α‐glucosidase and protein tyrosine phosphatase 1B.
- Published in:
- Chemical Biology & Drug Design, 2018, v. 92, n. 3, p. 1647, doi. 10.1111/cbdd.13331
- By:
- Publication type:
- Article
Molecular basis of benzimidazole inhibitors to hepatitis C virus envelope glycoprotein.
- Published in:
- Chemical Biology & Drug Design, 2018, v. 92, n. 3, p. 1638, doi. 10.1111/cbdd.13329
- By:
- Publication type:
- Article
Synthesis and antibacterial activities of novel pleuromutilin derivatives bearing an aminothiophenol moiety.
- Published in:
- Chemical Biology & Drug Design, 2018, v. 92, n. 3, p. 1627, doi. 10.1111/cbdd.13328
- By:
- Publication type:
- Article
Syntheses and evaluation of <sup>68</sup>Ga‐ and <sup>153</sup>Sm‐labeled DOTA‐conjugated bisphosphonate ligand for potential use in detection of skeletal metastases and management of pain arising from skeletal metastases.
- Published in:
- Chemical Biology & Drug Design, 2018, v. 92, n. 3, p. 1618, doi. 10.1111/cbdd.13327
- By:
- Publication type:
- Article
Discovery of benzimidazole‐based Leishmania mexicana cysteine protease CPB2.8ΔCTE inhibitors as potential therapeutics for leishmaniasis.
- Published in:
- Chemical Biology & Drug Design, 2018, v. 92, n. 3, p. 1585, doi. 10.1111/cbdd.13326
- By:
- Publication type:
- Article
Hydrocortisone inhibition of wild‐type and αD200Q nicotinic acetylcholine receptors.
- Published in:
- Chemical Biology & Drug Design, 2018, v. 92, n. 3, p. 1610, doi. 10.1111/cbdd.13325
- By:
- Publication type:
- Article
Design, synthesis, and biological evaluation of structurally constrained hybrid analogues containing ropinirole moiety as a novel class of potent and selective dopamine D3 receptor ligands.
- Published in:
- Chemical Biology & Drug Design, 2018, v. 92, n. 3, p. 1597, doi. 10.1111/cbdd.13324
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Chemical Biology & Drug Design, 2018, v. 92, n. 3, p. 1581, doi. 10.1111/cbdd.13100
- Publication type:
- Article